Difference between revisions of "Prima Europe"
| Line 2: | Line 2: | ||
In April 1998 Lord Taverne resigned from Prima, as a result of lobby-firm rules prohibiting employment of sitting MPs and peers, after its merger with [[GPC Market Access]]. GPC's clients included [[Pfizer]], [[Novartis]] and [[SmithKline Beecham]]. Three months after Taverne's departure his former Prima co-directors Derek Draper and Roger Liddle were at the centre of the 'lobbygate' 'cash for access' scandal . | In April 1998 Lord Taverne resigned from Prima, as a result of lobby-firm rules prohibiting employment of sitting MPs and peers, after its merger with [[GPC Market Access]]. GPC's clients included [[Pfizer]], [[Novartis]] and [[SmithKline Beecham]]. Three months after Taverne's departure his former Prima co-directors Derek Draper and Roger Liddle were at the centre of the 'lobbygate' 'cash for access' scandal . | ||
| + | |||
| + | ==Notes== | ||
| + | <references/> | ||
Revision as of 12:59, 13 September 2007
In the late 1980s Dick Taverne and Roger Liddle founded the consultancy firm Prima Europe. In 1990 Prima published The case for Biotechnology, a paper authored by Taverne. Liddle and Taverne were joined on Prima's board in 1996 by Derek Draper. Prima's clients included Unilever, RTZ, BNFL, and Glaxo Wellcome.
In April 1998 Lord Taverne resigned from Prima, as a result of lobby-firm rules prohibiting employment of sitting MPs and peers, after its merger with GPC Market Access. GPC's clients included Pfizer, Novartis and SmithKline Beecham. Three months after Taverne's departure his former Prima co-directors Derek Draper and Roger Liddle were at the centre of the 'lobbygate' 'cash for access' scandal .
